Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

New gene discovery could lead to a blood test for early Alzheimer’s disease detection

Staff Writer
Staff Writer 5 years ago
Updated 2020/03/31 at 2:04 PM
Share
SHARE

Detailed in their new findings, a group of researchers at the University of California, San Diego unveiled a new PHGDH gene discovery that could pave the way for the development of a blood test for detecting Alzheimer’s disease in its early stages.

As published in Current Biology, tests examining high blood levels of RNA produced by the gene can be a biomarker to detect the neurodegenerative disease in its early stages. RNA is vital for brain function and development among adolescents. For adults and the other population, the gene reduces production of those RNAs.

In the study, researchers aimed to identify possibility of clinical diagnosis much faster than our current abilities, which can be after considerable progression of cognitive deterioration in the brain.

Using SILVER-SEQ, researchers analyzed the exRNA profiles in the blood samples of more than 30 adults aged 70 and older over a span of one decade and a half. 15 of the participants were patients with Alzheimer’s disease, 11 were healthy at the start but developed Alzheimer’s later on, and 9 were regarded as healthy controls.

Based on the assessment of UC San Diego researchers, an excessive amount of extracellular RNA (exRNA) by the PHGDH gene could be a way to detect neurodegeneration early on in older adults.

Among the participants who started healthy but developed Alzheimer’s later on, researchers noticed a steady surge in PHGDH exRNA production two years before their official diagnosis. The healthy control group experienced no such changes in exRNA production.

“This is a retrospective study based on clinical follow-ups from the past, not a randomized clinical trial on a larger sample size. So we are not yet calling this a verified blood test for Alzheimer’s disease,” said Zixu Zhou, co-author of the study.

“Nevertheless, our data, which were from clinically collected samples, strongly support the discovery of a biomarker for predicting the development of Alzheimer’s disease.”

Photo: iStock

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds people change their mind about conspiracy theories but not often

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

TAGGED: PHGDH gene, Alzheimer's disease, cognition, dementia
Staff Writer March 31, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Researchers show how emotional stress leads to structural changes in the brain
Next Article Researchers show how neural and genetic factors influence the diagnosis of ADHD

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Social

Study finds people change their mind about conspiracy theories but not often

2 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?